Movatterモバイル変換


[0]ホーム

URL:


CN104922723A - Microporous hemostatic powder with coupling of plant starch and chitosan oligosaccharide and preparation method - Google Patents

Microporous hemostatic powder with coupling of plant starch and chitosan oligosaccharide and preparation method
Download PDF

Info

Publication number
CN104922723A
CN104922723ACN201510279398.1ACN201510279398ACN104922723ACN 104922723 ACN104922723 ACN 104922723ACN 201510279398 ACN201510279398 ACN 201510279398ACN 104922723 ACN104922723 ACN 104922723A
Authority
CN
China
Prior art keywords
oligochitosan
calcium chloride
preparation
solution
plant amylum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510279398.1A
Other languages
Chinese (zh)
Inventor
陈晚华
张军东
常臻
卜冰倩
吴剑英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Jianhua Fine Biological Products Co Ltd
Original Assignee
Shanghai Jianhua Fine Biological Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Jianhua Fine Biological Products Co LtdfiledCriticalShanghai Jianhua Fine Biological Products Co Ltd
Priority to CN201510279398.1ApriorityCriticalpatent/CN104922723A/en
Publication of CN104922723ApublicationCriticalpatent/CN104922723A/en
Pendinglegal-statusCriticalCurrent

Links

Landscapes

Abstract

The invention discloses microporous hemostatic powder with coupling of plant starch and chitosan oligosaccharide and a preparation method. The method relates to the field of biological medicines and comprises the following steps of decomposing chitosan to prepare the chitosan oligosaccharide, and mixing the chitosan oligosaccharide with the plant starch and calcium chloride according to certain proportion to prepare into powdery particles. The hemostatic powder disclosed by the invention is high in swelling rate and good in hemostatic effect and can be biodegraded, the preparation method is simple and the production cost is low.

Description

A kind of many micropores plant amylum coupling oligochitosan styptic powder and preparation method
Technical field
A kind of many micropores plant amylum coupling oligochitosan styptic powder and preparation method, this invention relates to biomedicine field, and being a kind ofly provides the technology that quick-acting haemostatic powder, cost are low, swelling ratio is high.
Background technology
Data shows, in modern war, even if having absolute technical advantage and fast after send the army of condition, still have the wounded of 20% before not accepting definitive treatment, die from battlefield one line, its main cause is severe loss of blood, even if transfer to rear medical institutions, the hemorrhage main cause being still death and complication generation.Therefore, the novel material of making a study of subjects of the applicable first aid of development just becomes the direction that military medicine scientific research department of various countries first develops.Along with the fast development of materialogy, first aid and surgical hemostasis investigation of materials have had rapid progress, but conventional hemostatic material still exists many deficiencies at present.
At present conventional hemostasis treatment material category is various, body surface point, the hemorrhage hemostatic material of planar, main rely on the chemical factors of material own to promote blood coagulation reaches localized plug or pressure dressing occluding vascular thus reaches hemostasis object.In China's emergency care of trauma, conventional body surface hemostatic material has first-aid kit, tourniquet etc.; The temperature sensing material that deep hemostasis material mainly contains the solid material such as microcoils, gelfoam and recently occurs.
Quick-acting haemostatic powder and functional hemostasis are the directions of following hemostatic material development.Develop various new wound hemostatic material at present, as: oligochitosan, microporous polysaccharide hemospheres, oxidized cellulose, olefin(e) acid esters tissue glue etc.
Oligochitosan is a kind of alkaline oligosaccharide being present in occurring in nature, is only made up of about 20 monosaccharide molecule, is a kind of elementary derivant of chitin deacetylase base.The main hemostatic mechanism of oligochitosan is that part positively charged in the molecule composition electronegative with erythrocyte, leukocyte and platelet etc. in blood combines, form Thromboembolus and then produce Blood clotting, and material such as cellular matrix secretion hyaluronic acid, cell growth factor etc. can be made to increase, promote wound healing.The Blood clotting of oligochitosan does not rely on thrombin and platelet, therefore can be applied in coagulation disorders patient.In addition, oligochitosan also has good antibacterial action, can suppress the growth of wound surface common bacteria and fungus.Oligochitosan Wound dressing has good water suction, breathability, compares traditional Wound dressing, and wound tissue can obtain enough partial pressure of oxygens, and then is conducive to growth and the reparation of epithelial tissue, can be suppressed to fibrocellular hyper-proliferative simultaneously, alleviates cicatrix reaction.At present, the sthptic sponge of oligochitosan coating, hemostatic gauze have been applied in first aid hemostasis and surgical operation, wherein add hemorrhage and can strengthen haemostatic effect.
Along with the development of modern technologies, no matter be complicated war wound or daily life, the incidence rate of damage improves just year by year, and this has higher requirement to first aid hemostatic treatment, and the material that development has better anthemorrhagic performance is imperative.As the material of bleeding-stopping dressing or hemorrhage except need possessing good anthemorrhagic performance, also need to possess excellent biocompatibility, the features such as toxic and side effects is little, easy to use.Meanwhile, along with the progress of materialogy, to original hemostatic material carry out physics, chemical property reprocessing with improve just become a kind of practical way.
Summary of the invention
The invention provides a kind of many micropores plant amylum coupling oligochitosan styptic powder and preparation method, this styptic powder is Biodegradable material, and be a kind of polysaccharide microsphere, main component is oligochitosan, calcium chloride and plant amylum.
Oligochitosan and plant amylum are the biological polysaccharides that can play two kinds of different clotting mechanisms respectively, possess good histocompatibility simultaneously.Both organic assembling are added simultaneously calcium chloride, liquid paraffin, Tween 80 be prepared into have many wrinkled surfaces, can the microsphere of water absorption and swelling fast, more excellent haemostatic effect can be played.
The oligochitosan styptic powder of the present invention is combined be prepared from by oligochitosan, calcium chloride, plant amylum, liquid paraffin, Tween 80, and wherein calcium chloride is cross-linking agent, and Tween 80 is emulsifying agent.
A kind of many micropores plant amylum coupling oligochitosan styptic powder and each composition proportion of preparation method are:
Oligochitosan 0.4 ~ 1.0g
Calcium chloride 0.4 ~ 0.8g
Plant amylum 0.4 ~ 1.0g
Liquid paraffin 125 ~ 500mL
Tween 80 8 ~ 38mL
Preparation method:
1. obtained aqueous solution: according to component proportion oligochitosan and plant amylum be dissolved in 50 ~ 100mL distilled water respectively and be mixed with aqueous solution, get both equivalent solution, be fully uniformly mixed, make aqueous solution;
2. prepare oil-phase solution: by proportioning by liquid paraffin and Tween 80 mixing, make oil-phase solution;
3. prepare calcium chloride solution: be dissolved in by calcium chloride in 12 ~ 25mL distilled water, stir, be mixed with calcium chloride solution;
4. prepare hydrogel microsphere: aqueous phase solution is added oil-phase solution, rapid stirring emulsifying, then add calcium chloride solution and fully stir, be cross-linked to form hydrogel microsphere, staticly settle, abandon supernatant;
5. washing dehydration: by precipitation petroleum ether, to remove liquid paraffin and Tween 80, then carries out serial dehydration with ethanol, final drying, makes powder.
With the particle diameter of particle size determination systematic survey oligochitosan styptic powder, its particle size range is between 10 ~ 100 μm.Scanning electron microscope shows, and granule is chondritic, and surface is covered with fold.Touch your fluid environment with wound fluid, granules swell rate reaches 300%, and in rabbit spleen model, haemostatic effect is obviously better than YUNNAN BAIYAO.
Detailed description of the invention
Now in conjunction with the embodiments, the present invention is elaborated:
Embodiment:
1. 1g oligochitosan and 1g plant amylum are dissolved in 100ml distilled water respectively;
2. oligochitosan solution is added plant amylum solution, be fully uniformly mixed;
3. above-mentioned mixed liquor is added rapid stirring 30min in the emulsion of 500ml liquid paraffin and 37.5ml Tween 80 composition, mixing speed is 1000 revs/min;
4. in above-mentioned solution, add 40ml2% calcium chloride solution, fully stir, be cross-linked to form hydrogel microsphere, staticly settle, discard supernatant solution;
5. use 100ml petroleum ether 3 times respectively, then become powder with 35%, 70%, 100% graded ethanol solutions dehydration, vacuum drying respectively.
Styptic powder of the present invention, preparation method is simple and convenient, low production cost, and product water absorption and swelling rate is high, easy to use, and haemostatic effect is excellent.

Claims (2)

CN201510279398.1A2015-05-282015-05-28Microporous hemostatic powder with coupling of plant starch and chitosan oligosaccharide and preparation methodPendingCN104922723A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN201510279398.1ACN104922723A (en)2015-05-282015-05-28Microporous hemostatic powder with coupling of plant starch and chitosan oligosaccharide and preparation method

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201510279398.1ACN104922723A (en)2015-05-282015-05-28Microporous hemostatic powder with coupling of plant starch and chitosan oligosaccharide and preparation method

Publications (1)

Publication NumberPublication Date
CN104922723Atrue CN104922723A (en)2015-09-23

Family

ID=54110362

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201510279398.1APendingCN104922723A (en)2015-05-282015-05-28Microporous hemostatic powder with coupling of plant starch and chitosan oligosaccharide and preparation method

Country Status (1)

CountryLink
CN (1)CN104922723A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN111053943A (en)*2018-10-162020-04-24中科院大连化学物理研究所张家港产业技术研究院有限公司Preparation method and application of hemostatic material
CN112717195A (en)*2021-01-142021-04-30上海长欧生物科技有限公司Biodegradable rapid hemostatic granule and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN1850111A (en)*2006-02-282006-10-25中国人民解放军第二军医大学Biodegradeable hemostasis powder
US20080145455A1 (en)*2006-12-132008-06-19Bedard Robert LCombination of Inorganic Hemostatic Agents with Other Hemostatic Agents
CN101574538A (en)*2009-06-112009-11-11官培龙Biodegradable compound powder-style hemostasis material
CN101584876A (en)*2009-06-192009-11-25山东赛克赛斯药业科技有限公司A kind of medical compound micropore polysaccharide and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN1850111A (en)*2006-02-282006-10-25中国人民解放军第二军医大学Biodegradeable hemostasis powder
US20080145455A1 (en)*2006-12-132008-06-19Bedard Robert LCombination of Inorganic Hemostatic Agents with Other Hemostatic Agents
CN101574538A (en)*2009-06-112009-11-11官培龙Biodegradable compound powder-style hemostasis material
CN101584876A (en)*2009-06-192009-11-25山东赛克赛斯药业科技有限公司A kind of medical compound micropore polysaccharide and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
陈耀华: "《人类健康的金钥匙 壳寡糖》", 31 August 2008, 中国医药科技出版社*

Cited By (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN111053943A (en)*2018-10-162020-04-24中科院大连化学物理研究所张家港产业技术研究院有限公司Preparation method and application of hemostatic material
CN112717195A (en)*2021-01-142021-04-30上海长欧生物科技有限公司Biodegradable rapid hemostatic granule and preparation method thereof
CN112717195B (en)*2021-01-142022-05-27上海长欧生物科技有限公司Biodegradable rapid hemostatic granule and preparation method thereof

Similar Documents

PublicationPublication DateTitle
Xie et al.Application of alginate-based hydrogels in hemostasis
Ghimire et al.Polymeric materials for hemostatic wound healing
Yao et al.A shape memory and antibacterial cryogel with rapid hemostasis for noncompressible hemorrhage and wound healing
Łabowska et al.Methods of extraction, physicochemical properties of alginates and their applications in biomedical field–a review
Wang et al.Preparation and evaluation of chitosan/alginate porous microspheres/Bletilla striata polysaccharide composite hemostatic sponges
CN100367933C (en) A biodegradable hemostatic powder
Li et al.Biodegradable microporous starch with assembled thrombin for rapid induction of hemostasis
Lv et al.Biodegradable alginate-based sponge with antibacterial and shape memory properties for penetrating wound hemostasis
CN101584876B (en)Medical compound micropore polysaccharide and application thereof
CN105688265A (en)Absorbable hemostatic material as well as preparation method and use thereof
CN105056283A (en)Preparation method of composite styptic powder
CN110522945A (en)Medical biogel hemostatic dressing and preparation method thereof
CN101559235A (en)Compound microporous starch powder hemostat and preparation method thereof
CN107501579B (en)Chitosan hemostatic material formed by covalent crosslinking and preparation method thereof
CN103467771A (en)Preparation method and application of marine organism active hemostasis dressing
CN104546893A (en)Biodegradable and absorbable hemostasis composition
CN102309776A (en)A kind of powdery absorbable hemostatics and preparation method thereof
CN104623718A (en)Chitosan petrolatum gauze and preparation method thereof
CN112321885A (en)Preparation and application of porous material assembled by graphene oxide and chitosan molecules
CN106822987B (en)A kind of preparation method of the porous ball hemostatic material of chitin-alginic acid salt
Wang et al.Calcium functioned carboxymethylated cotton fabric for hemostatic wound dressing
Fang et al.Cohering Plasma into Adhesive Gel by Natural Biopolymer–Nanoparticle Hybrid Powder for Efficient Hemostasis and Wound Healing
CN104922723A (en)Microporous hemostatic powder with coupling of plant starch and chitosan oligosaccharide and preparation method
Tan et al.Poly β-cyclodextrin/quaternary ammoniated chitosan cryogel with a porous structure for effective hemostasis
CN106902383B (en) A kind of modified dextran-modified nanogel hemostatic material and its preparation and application

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
SE01Entry into force of request for substantive examination
SE01Entry into force of request for substantive examination
RJ01Rejection of invention patent application after publication

Application publication date:20150923

RJ01Rejection of invention patent application after publication

[8]ページ先頭

©2009-2025 Movatter.jp